Son of ex-Honduran president sentenced to 24 years in prison

Image
AP New York
Last Updated : Sep 06 2017 | 7:48 AM IST
The son of former Honduran President Porfirio Lobo has been sentenced in New York to 24 years in prison after revealing his role in a cocaine trafficking conspiracy.
Fabio Lobo, 46, pleaded guilty in May 2016, admitting yesterday that he worked with drug traffickers and Honduran police to ship cocaine into the United States. US District Judge Lorna G. Schofield also fined him $50,000 and ordered him to forfeit $267,000.
Lobo confessed to a 2009 to 2014 conspiracy, nearly matching the years from 2010 to 2014 when his father was president.
The charge carried a mandatory minimum penalty of 10 years in prison and a maximum of life.
Lobo was brought to the US in May 2015 to face charges he conspired to smuggle over 5 kilograms of cocaine into the country.
Prior to the announcement of the sentence, Lobo cried and apologized.
In a release, Acting US Attorney Joon H. Kim said Lobo had sought to assist traffickers and enrich himself.
"Lobo used his father's position and his own connections to bring drug traffickers together with corrupt police and government officials," Kim said.
Prosecutors said Lobo had connected large-scale Honduran drug traffickers with high-level officials such as sitting Honduran congressmen as well as customs, military and law enforcement personnel.
They said he began engaging with drug traffickers while his father was running for president in 2009, enabling his father to receive bribes from members of a drug organization known as the Cachiros. Prosecutors said the organization used connections with politicians, military personnel and law enforcement to transport cocaine.
According to the release, the US government discovered that the drug organization paid over USD 500,000 to Lobo's father to secure political protection from law enforcement investigations, to prevent extradition to the US and to obtain contracts from Honduran government agencies for money laundering front companies used by the drug organisation.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 06 2017 | 7:48 AM IST

Next Story